Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase
Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase
复制标题
DOI:
10.1016/j.amjmed.2006.04.036
复制
发表时间:
2006-11-01
影响因子:
5.9
通讯作者:
Kumada, Hiromitsu
中科院分区:
文献类型:
--
作者:
Ikeda, Kenji;Arase, Yasuji;Kumada, Hiromitsu
PURPOSES: To elucidate the incidence of hepatitis activation and hepatocellular carcinogenesis in patients with negative HBe antigen and normal aminotransferase, long-term observation was performed in a retrospective cohort.METHODS: Among 116 consecutive patients with normal aminotransferase and negative HBe antigen at the time of liver biopsy, sequential frozen sera for initial 5 years were available for 95 patients. Hepatitis B virus ( HBV) DNA assay ( sensitivity > 400 copy/ mL) and aminotransferase were annually examined in the initial 5 years after biopsy.RESULTS: Liver biopsy showed minimal hepatitis ( F0) in 9, F1 in 53, F2 in 21, F3 in 6, and F4 or cirrhosis in 6. Initial HBV DNA concentration was low ( less than 10(4) copies/ mL) in 33, intermediate ( 10(4)- 10(6)) in 53, and high (10(6) or more) in 9. Hepatitis activation rates with twice as high as normal aminotransferase at the end of the third year were 12.1% in the low DNA group, 43.4% in the intermediate group, and 66.7% in the high DNA group. Initial HBV DNA values were significantly associated with future increase in aminotransferase ( P